Pharma News
Pharmaceutical
The US Food and Drug Administration has approved Japanese pharma major Takeda’s Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. The company’s shares rose 3% to 5,425 yen on the news. 6 August 2026
Pharmaceutical
Danish pharma major Novo Nordisk today revealed that the District Court of The Hague has granted the company a preliminary injunction against Ceban Ziekenhuisfarmacie, ordering the latter to immediately stop selling a compounded semaglutide nasal spray that infringes Novo Nordisk's intellectual property. 5 August 2026
Pharmaceutical
US radiopharmaceutical company Curium has entered into an agreement to merge with Lantheus Holdings, sending the latter’s share up 2.3% to $101.91 by mid-day on Monday. 4 August 2026
Most Read
Recent news
Pharmaceutical
Tenax Therapeutics saw its shares plummet 90% to $1.38, after it announced disappointing top-line results from the Phase III LEVEL clinical trial evaluating TNX-103 (oral levosimendan) in patients with pulmonary hypertension (PH)- preserved ejection fraction (HFpEF). 11 August 2026
Pharmaceutical
US clinical-stage biopharma Kailera Therapeutics, focused on elevating the next era of obesity care, today announced the appointment of Nur Nicholson as chief technology officer (CTO), effective August 31, 2026. 11 August 2026
Pharmaceutical
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but by improving treatment adherence, reducing medication burden and delivering more convenient treatment options, with long-acting therapies at the forefront. 11 August 2026
Pharmaceutical
Privately-held German biopharma company Isotope Technologies Munich (ITM) revealed that it has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its new drug application for 177Lu-edotreotide (ITM-11), an investigational agent for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). 11 August 2026
Pharmaceutical
The US Food and Drug Administration (FDA) approved Foundayo (orforglipron) on April 1 this year, for adults with obesity or overweight with weight-related medical problems. USA-based pharma major Eli Lilly (NYSE: LLY) began accepting prescriptions through its own LillyDirect platform immediately, with shipping from April 6. Broad availability through US retail pharmacies and telehealth providers began on April 9. 11 August 2026
Refine search
In Brief
Pharmaceutical
6 August 2026 There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.
Pharmaceutical
7 July 2026 Codis has agreed to acquire Catalent Pharma Solutions’ Nottingham, UK, facility, expanding its contract development and manufacturing organization (CDMO) capabilities in oral solid dose development and manufacturing. The deal is expected to close in the third quarter of 2026, subject to customary conditions.
Insights
Pharmaceutical
Russia is considering increasing drug procurements against hepatitis C. According to official data, governmental procurements of such drugs over the last year and a half has reached almost 50 billion roubles ($619.2 million), reports The Pharma Letter’s local correspondent. 5 August 2026
Pharmaceutical
In July 2025 the White House sent letters to 17 large drugmakers asking them to match, for American patients, the lowest prices they charge in other wealthy nations. A year on, all 17 have signed "most-favored-nation" (MFN) pricing deals. The administration says the group accounts for about 86% of the branded US market. 4 August 2026
Pharmaceutical
India’s pharmaceutical sector is undergoing a structural shift, with diabetes therapies and cardiac care driving growth well above the broader market. 3 August 2026
Pharmaceutical
Medicines regulators recorded a relatively quiet week in the seven days to 3 August 2026, with the USA accounting for the confirmed activity. 3 August 2026
Pharmaceutical
Russia is experiencing a boom of sales of drugs for sexual health, which are growing at double-digit rates these days, reports The Pharma Letter’s local correspondent. 27 July 2026
Pharmaceutical
India’s mergers and acquisitions (M&A) market hit a four-year high in the April to June quarter, powered by a single blockbuster: Sun Pharmaceutical Industries' $11.75 billion acquisition of Organon & Co. 25 July 2026
Pharmaceutical
An Expert View from Anders Neijber, Chief Medical Officer at Photocure and a urologist with more than 25 years’ experience in uro-oncology. 24 July 2026
Boardroom
Pharmaceutical
US clinical-stage biopharma Kailera Therapeutics, focused on elevating the next era of obesity care, today announced the appointment of Nur Nicholson as chief technology officer (CTO), effective August 31, 2026. 11 August 2026
Pharmaceutical
UK clinical-stage pharma NRG Therapeutics has announced the appointment of Dr Claus Sundgreen as chief medical officer (CMO), effective August 1, 2026. 3 August 2026
Pharmaceutical
US obesity specialist Ambrosia Biosciences has strengthened its clinical and scientific ranks, naming cardiometabolic drug developer Linda Shapiro Manning as chief medical officer and adding obesity researcher Randy Seeley to its scientific advisory board. The privately held Boulder, Colorado firm is preparing to move its lead oral candidate into first human trials. 28 July 2026
Pharmaceutical
US biopharma Neurocrine Biosciences (Nasdaq: NBIX) has appointed three senior vice presidents, a move the San Diego company cast as reinforcing its leadership team as it shifts from a business built largely on one product toward a broader neuroscience and rare disease group. 24 July 2026
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze